HU188274B - Process for producing condensed cycloalifatic derivatives of substituted pyrido (1,2-a)pyrimidones and pharmaceutical compositions containing them as acitve agents - Google Patents
Process for producing condensed cycloalifatic derivatives of substituted pyrido (1,2-a)pyrimidones and pharmaceutical compositions containing them as acitve agents Download PDFInfo
- Publication number
- HU188274B HU188274B HU831451A HU145183A HU188274B HU 188274 B HU188274 B HU 188274B HU 831451 A HU831451 A HU 831451A HU 145183 A HU145183 A HU 145183A HU 188274 B HU188274 B HU 188274B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- pyrido
- tetrahydro
- compound
- carboxylic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 12
- 239000008194 pharmaceutical composition Chemical class 0.000 title claims description 11
- FNKRSSCRFSZXBE-UHFFFAOYSA-N pyrido[1,2-a]pyrimidin-2-one Chemical class C1=CC=CC2=NC(=O)C=CN21 FNKRSSCRFSZXBE-UHFFFAOYSA-N 0.000 title 1
- -1 hydroxy, formyloxy Chemical group 0.000 claims abstract description 144
- 150000001875 compounds Chemical class 0.000 claims abstract description 125
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 33
- 239000001257 hydrogen Substances 0.000 claims abstract description 31
- 150000003839 salts Chemical class 0.000 claims abstract description 31
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 14
- 125000004076 pyridyl group Chemical group 0.000 claims abstract description 7
- 125000001544 thienyl group Chemical group 0.000 claims abstract description 7
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims abstract description 5
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 24
- 229910052736 halogen Inorganic materials 0.000 claims description 14
- 150000002367 halogens Chemical class 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 230000002862 amidating effect Effects 0.000 claims description 3
- DKWOHBPRFZIUQL-UHFFFAOYSA-N dimethyl-methylidene-oxo-$l^{6}-sulfane Chemical compound C[S+](C)([CH2-])=O DKWOHBPRFZIUQL-UHFFFAOYSA-N 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 2
- SOWBFZRMHSNYGE-UHFFFAOYSA-N Monoamide-Oxalic acid Natural products NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 claims description 2
- 230000032050 esterification Effects 0.000 claims description 2
- 238000005886 esterification reaction Methods 0.000 claims description 2
- 150000003857 carboxamides Chemical class 0.000 claims 2
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 claims 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims 1
- 125000005392 carboxamide group Chemical group NC(=O)* 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 12
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 125000005843 halogen group Chemical group 0.000 abstract description 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 206010027654 Allergic conditions Diseases 0.000 abstract 1
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 75
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 54
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 239000002244 precipitate Substances 0.000 description 29
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 22
- 239000000460 chlorine Substances 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 238000001816 cooling Methods 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 16
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- 238000010992 reflux Methods 0.000 description 15
- 159000000000 sodium salts Chemical class 0.000 description 14
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 10
- 239000005457 ice water Substances 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- 230000007935 neutral effect Effects 0.000 description 10
- KRNUKLBBDTUZTB-UHFFFAOYSA-N 3-benzylidene-1,2,3,10-tetrahydro-10-oxo-cyclopenta[d]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC=C1 KRNUKLBBDTUZTB-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 229910052801 chlorine Inorganic materials 0.000 description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 9
- LBMGFLVZIOZDHZ-UHFFFAOYSA-N 4h-pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1C=CN=C2C=CC(C(=O)O)=CN21 LBMGFLVZIOZDHZ-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 6
- 239000008101 lactose Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- UPGZAERNNNZSPM-UHFFFAOYSA-N quinazoline-8-carboxylic acid Chemical compound N1=CN=C2C(C(=O)O)=CC=CC2=C1 UPGZAERNNNZSPM-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 150000001299 aldehydes Chemical class 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- QHRQUMBXAYKEMS-UHFFFAOYSA-N 4-benzylidene-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC=C1 QHRQUMBXAYKEMS-UHFFFAOYSA-N 0.000 description 4
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 230000000767 anti-ulcer Effects 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 3
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 3
- QWUNOVHGZTXJEZ-UHFFFAOYSA-N 3-(2-methyl-benzylidene)-1,2,3,10-tetrahydro-10-oxo-cyclopenta[d]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CC1=CC=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CC1 QWUNOVHGZTXJEZ-UHFFFAOYSA-N 0.000 description 3
- SCBJPAJKWKCWHJ-UHFFFAOYSA-N 3-(3-methoxy-benzylidene)-1,2,3,10-tetrahydro-10-oxo-cyclopenta[d]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CC2)=C1 SCBJPAJKWKCWHJ-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- VBFVPBOTRXXBTR-UHFFFAOYSA-N 4-[(4-chlorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(Cl)C=C1 VBFVPBOTRXXBTR-UHFFFAOYSA-N 0.000 description 3
- OUTXTHGSFTULJT-UHFFFAOYSA-N 4-[(4-methoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 OUTXTHGSFTULJT-UHFFFAOYSA-N 0.000 description 3
- VCHKEIMBROKRIH-UHFFFAOYSA-N 6-[(2,3-dimethoxyphenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CC2)=C1OC VCHKEIMBROKRIH-UHFFFAOYSA-N 0.000 description 3
- AADABAOQXSLRGV-UHFFFAOYSA-N 7-chloro-1,2,3,10-tetrahydro-cyclopenta[d]pyrido[1,2-a]pyrimidine-10-one Chemical compound O=C1N2C=C(Cl)C=CC2=NC2=C1CCC2 AADABAOQXSLRGV-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- DLEKPPJSDIKZAN-UHFFFAOYSA-N 1,2-dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10 -one Chemical compound N1=C2C=CC=CN2C(=O)C2=C1CCC2 DLEKPPJSDIKZAN-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- BQDHJIPFPPPMPA-UHFFFAOYSA-N 11-oxo-4-(pyridin-3-ylmethylidene)-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CN=C1 BQDHJIPFPPPMPA-UHFFFAOYSA-N 0.000 description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
- TZSLLMQNITWHRP-UHFFFAOYSA-N 3-(3-ethoxy-benzylidene)-1,2,3,10-tetrahydro-10-oxo-cyclopenta[d]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CCOC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CC2)=C1 TZSLLMQNITWHRP-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- IFCCSWMUIIBUOV-UHFFFAOYSA-N 4-[(2,5-dimethoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound COC1=CC=C(OC)C(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1 IFCCSWMUIIBUOV-UHFFFAOYSA-N 0.000 description 2
- HMXLLKVGVZWJIL-UHFFFAOYSA-N 4-[(2-ethoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CCOC1=CC=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 HMXLLKVGVZWJIL-UHFFFAOYSA-N 0.000 description 2
- LXCQKKWEFALERK-UHFFFAOYSA-N 4-[(2-methoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound COC1=CC=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 LXCQKKWEFALERK-UHFFFAOYSA-N 0.000 description 2
- IYPZGKADMRNZIS-UHFFFAOYSA-N 4-[(2-methylphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CC1=CC=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 IYPZGKADMRNZIS-UHFFFAOYSA-N 0.000 description 2
- KHVVMCYCHDANHJ-UHFFFAOYSA-N 4-[(3,4-dichlorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(Cl)C(Cl)=C1 KHVVMCYCHDANHJ-UHFFFAOYSA-N 0.000 description 2
- ACDGPSFNSGPUJE-UHFFFAOYSA-N 4-[(3-ethoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CCOC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1 ACDGPSFNSGPUJE-UHFFFAOYSA-N 0.000 description 2
- XGIGFMCNYPQGIC-UHFFFAOYSA-N 4-[(3-methoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1 XGIGFMCNYPQGIC-UHFFFAOYSA-N 0.000 description 2
- YPMRRQPOABVGQI-UHFFFAOYSA-N 4-[(4-ethoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC(OCC)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 YPMRRQPOABVGQI-UHFFFAOYSA-N 0.000 description 2
- KXHUNPZLNBSDEW-UHFFFAOYSA-N 4-[(4-methylphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC(C)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 KXHUNPZLNBSDEW-UHFFFAOYSA-N 0.000 description 2
- PRKWNGZVLMLTBZ-UHFFFAOYSA-N 6-[(3-methylphenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound CC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CC2)=C1 PRKWNGZVLMLTBZ-UHFFFAOYSA-N 0.000 description 2
- LDNJLQJITIAGLI-UHFFFAOYSA-N 6-[(4-methoxyphenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CC1 LDNJLQJITIAGLI-UHFFFAOYSA-N 0.000 description 2
- MNDQKOHKXQFUTG-UHFFFAOYSA-N 7-methyl-1,2,3,10-tetrahydro-cyclopenta[d]pyrido[1,2-a]pyrimidine-10-one Chemical compound O=C1N2C=C(C)C=CC2=NC2=C1CCC2 MNDQKOHKXQFUTG-UHFFFAOYSA-N 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000002052 anaphylactic effect Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000027119 gastric acid secretion Effects 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- BTFQKIATRPGRBS-UHFFFAOYSA-N o-tolualdehyde Chemical compound CC1=CC=CC=C1C=O BTFQKIATRPGRBS-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- BPLKQGGAXWRFOE-UHFFFAOYSA-M trimethylsulfoxonium iodide Chemical compound [I-].C[S+](C)(C)=O BPLKQGGAXWRFOE-UHFFFAOYSA-M 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- UPRFGIZYNARKEU-UHFFFAOYSA-N 1,2,3,10-tetrahydro-10-oxo-cyclopenta[d]pyrido[1,2-a]pyrimidine-7-carboxylic acid methyl ester Chemical compound O=C1N2C=C(C(=O)OC)C=CC2=NC2=C1CCC2 UPRFGIZYNARKEU-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- XASJTZQZXNUQJO-UHFFFAOYSA-N 1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene Chemical class N1=C2C=CC=CN2CC2=C1CCC2 XASJTZQZXNUQJO-UHFFFAOYSA-N 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical class CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- IAUZGVAAUMYXMO-UHFFFAOYSA-N 1-ethyl-2-oxocyclopentane-1-carboxylic acid Chemical compound CCC1(C(O)=O)CCCC1=O IAUZGVAAUMYXMO-UHFFFAOYSA-N 0.000 description 1
- JPHFCIJSRWKXHC-UHFFFAOYSA-N 11-oxo-1,2-dihydropyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound O=C1N2C(=NC=3C=CCCC1=3)C=CC(=C2)C(=O)O JPHFCIJSRWKXHC-UHFFFAOYSA-N 0.000 description 1
- HIVKBIFBXSHGMX-UHFFFAOYSA-N 11-oxo-4-(3h-thiophen-2-ylidene)-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=C1CC=CS1 HIVKBIFBXSHGMX-UHFFFAOYSA-N 0.000 description 1
- QLKLPUYYQQGZGG-UHFFFAOYSA-N 11-oxo-4-(pyridin-2-ylmethylidene)-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC=N1 QLKLPUYYQQGZGG-UHFFFAOYSA-N 0.000 description 1
- BSHAVIHSWMYIIN-UHFFFAOYSA-N 11-oxo-4-(pyridin-4-ylmethylidene)-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=NC=C1 BSHAVIHSWMYIIN-UHFFFAOYSA-N 0.000 description 1
- CPJRBYDVCNFKQR-UHFFFAOYSA-N 11-oxo-4-[(2,3,4-trimethoxyphenyl)methylidene]-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 CPJRBYDVCNFKQR-UHFFFAOYSA-N 0.000 description 1
- OXBSUHWCWFMUCV-UHFFFAOYSA-N 11-oxo-4-[(2-propoxyphenyl)methylidene]-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CCCOC1=CC=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 OXBSUHWCWFMUCV-UHFFFAOYSA-N 0.000 description 1
- OFRVZADHQHPSEY-UHFFFAOYSA-N 12-bromo-6-[(2,3-dimethoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C=C(Br)C=CC4=N3)=O)CC2)=C1OC OFRVZADHQHPSEY-UHFFFAOYSA-N 0.000 description 1
- HHSUNYHMGQTCJC-UHFFFAOYSA-N 12-bromo-6-[(2,4-dichlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound ClC1=CC(Cl)=CC=C1C=C1C(N=C2N(C=C(Br)C=C2)C2=O)=C2CC1 HHSUNYHMGQTCJC-UHFFFAOYSA-N 0.000 description 1
- CXQWHTBPWGPBFQ-UHFFFAOYSA-N 12-bromo-6-[(2,6-dichlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound ClC1=CC=CC(Cl)=C1C=C1C(N=C2N(C=C(Br)C=C2)C2=O)=C2CC1 CXQWHTBPWGPBFQ-UHFFFAOYSA-N 0.000 description 1
- MHPVRAQSAYTDJV-UHFFFAOYSA-N 12-bromo-6-[(2-chlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound ClC1=CC=CC=C1C=C1C(N=C2N(C=C(Br)C=C2)C2=O)=C2CC1 MHPVRAQSAYTDJV-UHFFFAOYSA-N 0.000 description 1
- JGMBMMPSMASNAU-UHFFFAOYSA-N 12-bromo-6-[(4-chlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=CC(Cl)=CC=C1C=C1C(N=C2N(C=C(Br)C=C2)C2=O)=C2CC1 JGMBMMPSMASNAU-UHFFFAOYSA-N 0.000 description 1
- WAMLQLDGCXNZCB-UHFFFAOYSA-N 12-chloro-6-[(2,3,4-trimethoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=C(OC)C(OC)=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 WAMLQLDGCXNZCB-UHFFFAOYSA-N 0.000 description 1
- QOCYKXPIZWGOAF-UHFFFAOYSA-N 12-chloro-6-[(2,3-diethoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound CCOC1=CC=CC(C=C2C3=C(C(N4C=C(Cl)C=CC4=N3)=O)CC2)=C1OCC QOCYKXPIZWGOAF-UHFFFAOYSA-N 0.000 description 1
- QUQDHQNWUFRXLF-UHFFFAOYSA-N 12-chloro-6-[(2,3-dimethoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C=C(Cl)C=CC4=N3)=O)CC2)=C1OC QUQDHQNWUFRXLF-UHFFFAOYSA-N 0.000 description 1
- YDHIPJTVUKBCAB-UHFFFAOYSA-N 12-chloro-6-[(2,4-dimethoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=CC(OC)=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 YDHIPJTVUKBCAB-UHFFFAOYSA-N 0.000 description 1
- XFSKSNYMWIGOMI-UHFFFAOYSA-N 12-chloro-6-[(2,5-dimethoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=CC=C(OC)C(C=C2C3=C(C(N4C=C(Cl)C=CC4=N3)=O)CC2)=C1 XFSKSNYMWIGOMI-UHFFFAOYSA-N 0.000 description 1
- RBCHXISRCDTTRL-UHFFFAOYSA-N 12-chloro-6-[(2,6-dichlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Cl)C=CC3=NC=2C1=CC1=C(Cl)C=CC=C1Cl RBCHXISRCDTTRL-UHFFFAOYSA-N 0.000 description 1
- NTWGPTSTWWJHPZ-UHFFFAOYSA-N 12-chloro-6-[(2-chlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Cl)C=CC3=NC=2C1=CC1=CC=CC=C1Cl NTWGPTSTWWJHPZ-UHFFFAOYSA-N 0.000 description 1
- AMWIPOAGDOUNIX-UHFFFAOYSA-N 12-chloro-6-[(2-methoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=CC=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 AMWIPOAGDOUNIX-UHFFFAOYSA-N 0.000 description 1
- GAPDMJGIXDHEQV-UHFFFAOYSA-N 12-chloro-6-[(2-methylphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound CC1=CC=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 GAPDMJGIXDHEQV-UHFFFAOYSA-N 0.000 description 1
- LAFMITCPYCDUPM-UHFFFAOYSA-N 12-chloro-6-[(3,4-dichlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Cl)C=CC3=NC=2C1=CC1=CC=C(Cl)C(Cl)=C1 LAFMITCPYCDUPM-UHFFFAOYSA-N 0.000 description 1
- OLZDDEPOMVJIRI-UHFFFAOYSA-N 12-chloro-6-[(3-ethoxy-2-methoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound CCOC1=CC=CC(C=C2C3=C(C(N4C=C(Cl)C=CC4=N3)=O)CC2)=C1OC OLZDDEPOMVJIRI-UHFFFAOYSA-N 0.000 description 1
- RTPZINDNYUJDQH-UHFFFAOYSA-N 12-chloro-6-[(3-methoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C=C(Cl)C=CC4=N3)=O)CC2)=C1 RTPZINDNYUJDQH-UHFFFAOYSA-N 0.000 description 1
- WLVUBKLIGTZCBF-UHFFFAOYSA-N 12-chloro-6-[(4-chlorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=CC(Cl)=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 WLVUBKLIGTZCBF-UHFFFAOYSA-N 0.000 description 1
- OOCVMWHFOAMADD-UHFFFAOYSA-N 12-chloro-6-[(4-fluorophenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=CC(F)=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 OOCVMWHFOAMADD-UHFFFAOYSA-N 0.000 description 1
- SDXXCLHZSQLDDQ-UHFFFAOYSA-N 12-chloro-6-[(4-methoxyphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=CC(OC)=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 SDXXCLHZSQLDDQ-UHFFFAOYSA-N 0.000 description 1
- GUTMYXDYGYVOQA-UHFFFAOYSA-N 12-chloro-6-[(4-methylphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=CC(C)=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CC1 GUTMYXDYGYVOQA-UHFFFAOYSA-N 0.000 description 1
- BPQOEXQXFFMUOE-UHFFFAOYSA-N 12-methyl-6-[(2-methylphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(C)C=CC3=NC=2C1=CC1=CC=CC=C1C BPQOEXQXFFMUOE-UHFFFAOYSA-N 0.000 description 1
- FESSICYANYUMKF-UHFFFAOYSA-N 12-methyl-6-[(3-methylphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound CC1=CC=CC(C=C2C3=C(C(N4C=C(C)C=CC4=N3)=O)CC2)=C1 FESSICYANYUMKF-UHFFFAOYSA-N 0.000 description 1
- YNZMICGACAABPN-UHFFFAOYSA-N 12-methyl-6-[(4-methylphenyl)methylidene]-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=CC(C)=CC=C1C=C1C(N=C2N(C=C(C)C=C2)C2=O)=C2CC1 YNZMICGACAABPN-UHFFFAOYSA-N 0.000 description 1
- AQVWMIXYCJXOCN-UHFFFAOYSA-N 1H-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1C2=CN3C(=NC2=CC=C1)C=CC(=C3)C(=O)O AQVWMIXYCJXOCN-UHFFFAOYSA-N 0.000 description 1
- TYIFOIUTIBJJDB-UHFFFAOYSA-N 2-(diethylamino)ethyl quinazoline-8-carboxylate Chemical compound CCN(CC)CCOC(=O)C1=C2N=CN=CC2=CC=C1 TYIFOIUTIBJJDB-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 150000003930 2-aminopyridines Chemical class 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- 229940013085 2-diethylaminoethanol Drugs 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 1
- XMBBFXBWKRCFCT-UHFFFAOYSA-N 2-oxo-6-(pyridin-4-ylmethylidene)-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=NC=C1 XMBBFXBWKRCFCT-UHFFFAOYSA-N 0.000 description 1
- UJYPOOQIFXTDLJ-UHFFFAOYSA-N 3-(3-hydroxy-benzylidene)-1,2,3,10-tetrahydro-10-oxo-cyclopenta[d]pyrido[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC(O)=C1 UJYPOOQIFXTDLJ-UHFFFAOYSA-N 0.000 description 1
- UIQXFYNFUQRLMY-UHFFFAOYSA-N 3-benzylidene-1,2,3,10-tetrahydro-10-oxo-cyclopenta[d]pyrido[1,2-a]pyrimidine-7-carboxamide Chemical compound C1CC=2C(=O)N3C=C(C(=O)N)C=CC3=NC=2C1=CC1=CC=CC=C1 UIQXFYNFUQRLMY-UHFFFAOYSA-N 0.000 description 1
- MTQPILPPIDNQQX-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-ylmethylidene)-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=C2OCOC2=CC(C=C2C=3N=C4C=CC(=CN4C(=O)C=3CCC2)C(=O)O)=C1 MTQPILPPIDNQQX-UHFFFAOYSA-N 0.000 description 1
- FLESJLOTERFIMR-UHFFFAOYSA-N 4-[(2,3-dimethoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1OC FLESJLOTERFIMR-UHFFFAOYSA-N 0.000 description 1
- WEFJFKXWWTVDHA-UHFFFAOYSA-N 4-[(2,3-dimethoxyphenyl)methylidene]-8-oxo-2,9-diazatetracyclo[7.5.0.03,7.010,12]tetradeca-1,3(7),13-triene-12-carboxylic acid Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C5CC5(C=CC4=N3)C(O)=O)=O)CC2)=C1OC WEFJFKXWWTVDHA-UHFFFAOYSA-N 0.000 description 1
- NZPIAWRECUJCGF-UHFFFAOYSA-N 4-[(2,4-dichlorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(Cl)C=C1Cl NZPIAWRECUJCGF-UHFFFAOYSA-N 0.000 description 1
- VNRVWUWYNQBPFF-UHFFFAOYSA-N 4-[(2,4-dimethylphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CC1=CC(C)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 VNRVWUWYNQBPFF-UHFFFAOYSA-N 0.000 description 1
- PQQPWSKHNMAURX-UHFFFAOYSA-N 4-[(2,5-dimethylphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CC1=CC=C(C)C(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1 PQQPWSKHNMAURX-UHFFFAOYSA-N 0.000 description 1
- SSKVMKULDOBLNO-UHFFFAOYSA-N 4-[(2,5-dimethylphenyl)methylidene]-8-methyl-2,3-dihydro-1H-pyrido[2,1-b]quinazolin-11-one Chemical compound CC1=CC=C(C)C(C=C2C3=C(C(N4C=C(C)C=CC4=N3)=O)CCC2)=C1 SSKVMKULDOBLNO-UHFFFAOYSA-N 0.000 description 1
- ZNHJBGDEZYIZGN-UHFFFAOYSA-N 4-[(2,6-dichlorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=C(Cl)C=CC=C1Cl ZNHJBGDEZYIZGN-UHFFFAOYSA-N 0.000 description 1
- JGGNHOBUOJSACV-UHFFFAOYSA-N 4-[(2-chlorophenyl)methylidene]-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound ClC1=CC=CC=C1C=C1C(N=C2N(C=CC=C2)C2=O)=C2CCC1 JGGNHOBUOJSACV-UHFFFAOYSA-N 0.000 description 1
- QOZYMIPUVRSGLT-UHFFFAOYSA-N 4-[(2-methylphenyl)methylidene]-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound CC1=CC=CC=C1C=C1C(N=C2N(C=CC=C2)C2=O)=C2CCC1 QOZYMIPUVRSGLT-UHFFFAOYSA-N 0.000 description 1
- LQQCYDHSLAYALC-UHFFFAOYSA-N 4-[(2-methylphenyl)methylidene]-8-oxo-2,9-diazatetracyclo[7.5.0.03,7.010,12]tetradeca-1,3(7),13-triene-12-carboxylic acid Chemical compound CC1=CC=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CC1 LQQCYDHSLAYALC-UHFFFAOYSA-N 0.000 description 1
- BORPHRRHFATQHI-UHFFFAOYSA-N 4-[(2-nitrophenyl)methylidene]-11-oxo-2,3-dihydro-1H-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC=C1[N+]([O-])=O BORPHRRHFATQHI-UHFFFAOYSA-N 0.000 description 1
- HHYAJVADERPWHO-UHFFFAOYSA-N 4-[(3,4-dimethoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 HHYAJVADERPWHO-UHFFFAOYSA-N 0.000 description 1
- PDWMBPLQSIEPQH-UHFFFAOYSA-N 4-[(3-aminophenyl)methylidene]-11-oxo-2,3-dihydro-1H-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound NC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1 PDWMBPLQSIEPQH-UHFFFAOYSA-N 0.000 description 1
- LFQHFJNMSCYEPD-UHFFFAOYSA-N 4-[(3-chlorophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC(Cl)=C1 LFQHFJNMSCYEPD-UHFFFAOYSA-N 0.000 description 1
- FSADGQJCNUPMIA-UHFFFAOYSA-N 4-[(3-ethoxy-2-methoxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound CCOC1=CC=CC(C=C2C3=C(C(N4C=C(C=CC4=N3)C(O)=O)=O)CCC2)=C1OC FSADGQJCNUPMIA-UHFFFAOYSA-N 0.000 description 1
- DYBMJXCTMBLPBB-UHFFFAOYSA-N 4-[(3-hydroxyphenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC(O)=C1 DYBMJXCTMBLPBB-UHFFFAOYSA-N 0.000 description 1
- NGEVNRHAIPFVHC-UHFFFAOYSA-N 4-[(4-acetamidophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC(NC(=O)C)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 NGEVNRHAIPFVHC-UHFFFAOYSA-N 0.000 description 1
- ISZPLXJYYVDYOJ-UHFFFAOYSA-N 4-[(4-aminophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1=CC(N)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CCC1 ISZPLXJYYVDYOJ-UHFFFAOYSA-N 0.000 description 1
- VIICAXIDWOOALO-UHFFFAOYSA-N 4-[(4-aminophenyl)methylidene]-8-methyl-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound C1CCC=2C(=O)N3C=C(C)C=CC3=NC=2C1=CC1=CC=C(N)C=C1 VIICAXIDWOOALO-UHFFFAOYSA-N 0.000 description 1
- XCFKRPTVELAGOA-UHFFFAOYSA-N 4-[(4-ethoxyphenyl)methylidene]-9-oxo-2,10-diazatetracyclo[8.5.0.03,8.011,13]pentadeca-1,3(8),14-triene-13-carboxylic acid Chemical compound C1=CC(OCC)=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CCC1 XCFKRPTVELAGOA-UHFFFAOYSA-N 0.000 description 1
- CZQHLHXXVZYXRM-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)methylidene]-11-oxo-2,3-dihydro-1H-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(O)C=C1 CZQHLHXXVZYXRM-UHFFFAOYSA-N 0.000 description 1
- NGAHNAGBLZXGLC-UHFFFAOYSA-N 4-[(4-methoxyphenyl)methylidene]-9-oxo-2,10-diazatetracyclo[8.5.0.03,8.011,13]pentadeca-1,3(8),14-triene-13-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CCC1 NGAHNAGBLZXGLC-UHFFFAOYSA-N 0.000 description 1
- ICSWYMANNLRTKJ-UHFFFAOYSA-N 4-[(4-methylphenyl)methylidene]-8-oxo-2,9-diazatetracyclo[7.5.0.03,7.010,12]tetradeca-1,3(7),13-triene-12-carboxylic acid Chemical compound C1=CC(C)=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CC1 ICSWYMANNLRTKJ-UHFFFAOYSA-N 0.000 description 1
- JYTXIERHICQZJM-UHFFFAOYSA-N 4-[(4-methylphenyl)methylidene]-9-oxo-2,10-diazatetracyclo[8.5.0.03,8.011,13]pentadeca-1,3(8),14-triene-13-carboxylic acid Chemical compound C1=CC(C)=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CCC1 JYTXIERHICQZJM-UHFFFAOYSA-N 0.000 description 1
- KDHSBNGEMHULPX-UHFFFAOYSA-N 4-[(4-nitrophenyl)methylidene]-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazoline-8-carboxylic acid Chemical compound C1CCC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C([N+]([O-])=O)C=C1 KDHSBNGEMHULPX-UHFFFAOYSA-N 0.000 description 1
- OXYGMYHYCPGJLY-UHFFFAOYSA-N 4-benzylidene-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound C1=2N=C3C=CC=CN3C(=O)C=2CCCC1=CC1=CC=CC=C1 OXYGMYHYCPGJLY-UHFFFAOYSA-N 0.000 description 1
- GKDBGIRHHVCRRG-UHFFFAOYSA-N 4-benzylidene-7-methyl-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound C1=C(C)C=CN(C(C=2CCC3)=O)C1=NC=2C3=CC1=CC=CC=C1 GKDBGIRHHVCRRG-UHFFFAOYSA-N 0.000 description 1
- RELCONTUWUCMFU-UHFFFAOYSA-N 4-benzylidene-8-methyl-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound C1CCC=2C(=O)N3C=C(C)C=CC3=NC=2C1=CC1=CC=CC=C1 RELCONTUWUCMFU-UHFFFAOYSA-N 0.000 description 1
- APQMTCKETULICB-UHFFFAOYSA-N 4-benzylidene-8-oxo-2,9-diazatetracyclo[7.5.0.03,7.010,12]tetradeca-1,3(7),13-triene-12-carboxylic acid Chemical compound C1=CC2(C(=O)O)CC2N(C(C=2CC3)=O)C1=NC=2C3=CC1=CC=CC=C1 APQMTCKETULICB-UHFFFAOYSA-N 0.000 description 1
- DBKXNUHXVLFCII-UHFFFAOYSA-N 4-benzylidene-9-oxo-2,10-diazatetracyclo[8.5.0.03,8.011,13]pentadeca-1,3(8),14-triene-13-carboxylic acid Chemical compound C1=CC2(C(=O)O)CC2N(C(C=2CCC3)=O)C1=NC=2C3=CC1=CC=CC=C1 DBKXNUHXVLFCII-UHFFFAOYSA-N 0.000 description 1
- RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- MBNYPWSXYHJXSC-UHFFFAOYSA-N 4H-pyrido[1,2-a]pyrimidine-7-carboxamide Chemical compound N1=C2N(CC=C1)C=C(C=C2)C(=O)N MBNYPWSXYHJXSC-UHFFFAOYSA-N 0.000 description 1
- VFMCUTPRJLZEEW-UHFFFAOYSA-N 4h-pyrido[1,2-a]pyrimidine Chemical class C1=CC=CN2CC=CN=C21 VFMCUTPRJLZEEW-UHFFFAOYSA-N 0.000 description 1
- GGFJCEXIYJPMDN-UHFFFAOYSA-N 6-(1,3-benzodioxol-5-ylmethylidene)-12-chloro-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=C2OCOC2=CC(C=C2C=3N=C4C=CC(=CN4C(=O)C=3CC2)Cl)=C1 GGFJCEXIYJPMDN-UHFFFAOYSA-N 0.000 description 1
- BFFFKMUSALLXMM-UHFFFAOYSA-N 6-(1,3-benzodioxol-5-ylmethylidene)-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1=C2OCOC2=CC(C=C2C=3N=C4C=CC(=CN4C(=O)C=3CC2)C(=O)O)=C1 BFFFKMUSALLXMM-UHFFFAOYSA-N 0.000 description 1
- XUPLQBFFJIMFJQ-UHFFFAOYSA-N 6-[(2,4-dichlorophenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(Cl)C=C1Cl XUPLQBFFJIMFJQ-UHFFFAOYSA-N 0.000 description 1
- CQWAKILUKBKVOG-UHFFFAOYSA-N 6-[(2,4-dimethylphenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound CC1=CC(C)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CC1 CQWAKILUKBKVOG-UHFFFAOYSA-N 0.000 description 1
- NVVPWRNVQLRQRQ-UHFFFAOYSA-N 6-[(2,6-dichlorophenyl)methylidene]-10-methoxy-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=CC=CN(C(C=2CC3)=O)C1=NC=2C3=CC1=C(Cl)C=CC=C1Cl NVVPWRNVQLRQRQ-UHFFFAOYSA-N 0.000 description 1
- YRNFHSYEYQULPO-UHFFFAOYSA-N 6-[(2,6-dichlorophenyl)methylidene]-12-methyl-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(C)C=CC3=NC=2C1=CC1=C(Cl)C=CC=C1Cl YRNFHSYEYQULPO-UHFFFAOYSA-N 0.000 description 1
- IXKBFLKRNDZNIX-UHFFFAOYSA-N 6-[(2,6-dichlorophenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=C(Cl)C=CC=C1Cl IXKBFLKRNDZNIX-UHFFFAOYSA-N 0.000 description 1
- TXHZECGPALWGNK-UHFFFAOYSA-N 6-[(2-chlorophenyl)methylidene]-10-methoxy-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=CC=CN(C(C=2CC3)=O)C1=NC=2C3=CC1=CC=CC=C1Cl TXHZECGPALWGNK-UHFFFAOYSA-N 0.000 description 1
- JPYBHWSSLNUMQQ-UHFFFAOYSA-N 6-[(2-chlorophenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC=C1Cl JPYBHWSSLNUMQQ-UHFFFAOYSA-N 0.000 description 1
- HLCNBBIMOLNUPB-UHFFFAOYSA-N 6-[(2-ethoxyphenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound CCOC1=CC=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CC1 HLCNBBIMOLNUPB-UHFFFAOYSA-N 0.000 description 1
- STUQRBVWERYQKF-UHFFFAOYSA-N 6-[(2-methoxyphenyl)methylidene]-12-methyl-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound COC1=CC=CC=C1C=C1C(N=C2N(C=C(C)C=C2)C2=O)=C2CC1 STUQRBVWERYQKF-UHFFFAOYSA-N 0.000 description 1
- ANLQZIGVAWGAEV-UHFFFAOYSA-N 6-[(2-methoxyphenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound COC1=CC=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CC1 ANLQZIGVAWGAEV-UHFFFAOYSA-N 0.000 description 1
- VRHUZEDZFSQYNE-UHFFFAOYSA-N 6-[(3,4-dichlorophenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(Cl)C(Cl)=C1 VRHUZEDZFSQYNE-UHFFFAOYSA-N 0.000 description 1
- FSZXRXAGYGVFLN-UHFFFAOYSA-N 6-[(3-chlorophenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=CC(Cl)=C1 FSZXRXAGYGVFLN-UHFFFAOYSA-N 0.000 description 1
- IYALGXCLEWIOEZ-UHFFFAOYSA-N 6-[(4-ethoxyphenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1=CC(OCC)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CC1 IYALGXCLEWIOEZ-UHFFFAOYSA-N 0.000 description 1
- AGVXUWSAJIYXCM-UHFFFAOYSA-N 6-[(4-fluorophenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1CC=2C(=O)N3C=C(C(=O)O)C=CC3=NC=2C1=CC1=CC=C(F)C=C1 AGVXUWSAJIYXCM-UHFFFAOYSA-N 0.000 description 1
- ONMGYOQGCYPXOU-UHFFFAOYSA-N 6-[(4-methoxyphenyl)methylidene]-12-methyl-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1=CC(OC)=CC=C1C=C1C(N=C2N(C=C(C)C=C2)C2=O)=C2CC1 ONMGYOQGCYPXOU-UHFFFAOYSA-N 0.000 description 1
- DLMUOWJZIAEMHS-UHFFFAOYSA-N 6-[(4-methylphenyl)methylidene]-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carboxylic acid Chemical compound C1=CC(C)=CC=C1C=C1C(N=C2N(C=C(C=C2)C(O)=O)C2=O)=C2CC1 DLMUOWJZIAEMHS-UHFFFAOYSA-N 0.000 description 1
- GBLHSBJTLODTGL-UHFFFAOYSA-N 6-benzylidene-10,12-dibromo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Br)C=C(Br)C3=NC=2C1=CC1=CC=CC=C1 GBLHSBJTLODTGL-UHFFFAOYSA-N 0.000 description 1
- CNLJKQJZTLFBBG-UHFFFAOYSA-N 6-benzylidene-10,12-dichloro-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Cl)C=C(Cl)C3=NC=2C1=CC1=CC=CC=C1 CNLJKQJZTLFBBG-UHFFFAOYSA-N 0.000 description 1
- YOEDRESVXYAKCK-UHFFFAOYSA-N 6-benzylidene-12-bromo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Br)C=CC3=NC=2C1=CC1=CC=CC=C1 YOEDRESVXYAKCK-UHFFFAOYSA-N 0.000 description 1
- NQGMKXIPKHIDAJ-UHFFFAOYSA-N 6-benzylidene-12-chloro-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraen-2-one Chemical compound C1CC=2C(=O)N3C=C(Cl)C=CC3=NC=2C1=CC1=CC=CC=C1 NQGMKXIPKHIDAJ-UHFFFAOYSA-N 0.000 description 1
- WQGFRQSRLRMVRM-UHFFFAOYSA-N 6-benzylidene-2-oxo-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),8,10,12-tetraene-12-carbonitrile Chemical compound C1=2N=C3C=CC(C#N)=CN3C(=O)C=2CCC1=CC1=CC=CC=C1 WQGFRQSRLRMVRM-UHFFFAOYSA-N 0.000 description 1
- NBHHSRJCDBQEBM-UHFFFAOYSA-N 7-chloro-3-(3,4,5-trimethoxy-benzylidene)-1,2,3,10-tetrahydro-cyclopenta[d]pyrido[1,2-a]pyrimidine-10-one Chemical compound COC1=C(OC)C(OC)=CC(C=C2C3=C(C(N4C=C(Cl)C=CC4=N3)=O)CC2)=C1 NBHHSRJCDBQEBM-UHFFFAOYSA-N 0.000 description 1
- USYRHTQSYBBCSD-UHFFFAOYSA-N 8-chloro-4-(pyridin-3-ylmethylidene)-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound C1CCC=2C(=O)N3C=C(Cl)C=CC3=NC=2C1=CC1=CC=CN=C1 USYRHTQSYBBCSD-UHFFFAOYSA-N 0.000 description 1
- UIYVHTWLGFQDHG-UHFFFAOYSA-N 8-chloro-4-[(2-methylphenyl)methylidene]-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound CC1=CC=CC=C1C=C1C(N=C2N(C=C(Cl)C=C2)C2=O)=C2CCC1 UIYVHTWLGFQDHG-UHFFFAOYSA-N 0.000 description 1
- TXSKSNNREHMMES-UHFFFAOYSA-N 8-methyl-4-(pyridin-2-ylmethylidene)-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound C1CCC=2C(=O)N3C=C(C)C=CC3=NC=2C1=CC1=CC=CC=N1 TXSKSNNREHMMES-UHFFFAOYSA-N 0.000 description 1
- IGMBDCCWWHVDSI-UHFFFAOYSA-N 8-methyl-4-(pyridin-4-ylmethylidene)-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-11-one Chemical compound C1CCC=2C(=O)N3C=C(C)C=CC3=NC=2C1=CC1=CC=NC=C1 IGMBDCCWWHVDSI-UHFFFAOYSA-N 0.000 description 1
- YTSXCGHLAZPIKB-UHFFFAOYSA-N 8-methyl-4-[(4-methylphenyl)methylidene]-2,3-dihydro-1H-pyrido[2,1-b]quinazolin-11-one Chemical compound C1=CC(C)=CC=C1C=C1C(N=C2N(C=C(C)C=C2)C2=O)=C2CCC1 YTSXCGHLAZPIKB-UHFFFAOYSA-N 0.000 description 1
- ACGFUWIDNKDJDD-UHFFFAOYSA-N 9-oxo-4-[(2,3,4-trimethoxyphenyl)methylidene]-2,10-diazatetracyclo[8.5.0.03,8.011,13]pentadeca-1,3(8),14-triene-13-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CCC1 ACGFUWIDNKDJDD-UHFFFAOYSA-N 0.000 description 1
- VENRQQORTDABIG-UHFFFAOYSA-N 9-oxo-4-[(3,4,5-trimethoxyphenyl)methylidene]-2,10-diazatetracyclo[8.5.0.03,8.011,13]pentadeca-1,3(8),14-triene-13-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC(C=C2C3=C(C(N4C5CC5(C=CC4=N3)C(O)=O)=O)CCC2)=C1 VENRQQORTDABIG-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 208000000104 Arthus reaction Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- SAIKULLUBZKPDA-UHFFFAOYSA-N Bis(2-ethylhexyl) amine Chemical compound CCCCC(CC)CNCC(CC)CCCC SAIKULLUBZKPDA-UHFFFAOYSA-N 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- GUXRLVHRIPARJY-UHFFFAOYSA-N C(C)OC(=O)C=1C=CC=2N(C(C3=C(N2)C(CC3)=CC3=CC=C(C=C3)OC)=O)C1 Chemical compound C(C)OC(=O)C=1C=CC=2N(C(C3=C(N2)C(CC3)=CC3=CC=C(C=C3)OC)=O)C1 GUXRLVHRIPARJY-UHFFFAOYSA-N 0.000 description 1
- XNWFNTZWVJMCFK-UHFFFAOYSA-N C1=CC2(C(=O)O)CC2N(C(C=2CC3)=O)C1=NC=2C3=CC1=CC=C(F)C=C1 Chemical compound C1=CC2(C(=O)O)CC2N(C(C=2CC3)=O)C1=NC=2C3=CC1=CC=C(F)C=C1 XNWFNTZWVJMCFK-UHFFFAOYSA-N 0.000 description 1
- ZQNPYCDNOLLMFQ-UHFFFAOYSA-N C1=CC2(C(=O)O)CC2N(C(C=2CCC3)=O)C1=NC=2C3=CC1=CC=C(Cl)C(Cl)=C1 Chemical compound C1=CC2(C(=O)O)CC2N(C(C=2CCC3)=O)C1=NC=2C3=CC1=CC=C(Cl)C(Cl)=C1 ZQNPYCDNOLLMFQ-UHFFFAOYSA-N 0.000 description 1
- UDRUQULGELSHII-UHFFFAOYSA-N CCOC1=CC=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CC1 Chemical compound CCOC1=CC=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CC1 UDRUQULGELSHII-UHFFFAOYSA-N 0.000 description 1
- HOQGUZNPRYUFGP-UHFFFAOYSA-N COC1=CC=CC(C=C2C3=C(C(N4C5CC5(C=CC4=N3)C(O)=O)=O)CC2)=C1 Chemical compound COC1=CC=CC(C=C2C3=C(C(N4C5CC5(C=CC4=N3)C(O)=O)=O)CC2)=C1 HOQGUZNPRYUFGP-UHFFFAOYSA-N 0.000 description 1
- BBVQATJTMRRLTG-UHFFFAOYSA-N COC1=CC=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CC1 Chemical compound COC1=CC=CC=C1C=C1C(N=C2N(C3CC3(C=C2)C(O)=O)C2=O)=C2CC1 BBVQATJTMRRLTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical class NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 206010053614 Type III immune complex mediated reaction Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- ADGSLKNSDCJMNW-UHFFFAOYSA-M [Na+].ClC1=C(C=C2CCCC=3C(N4C(=NC23)C=CC(=C4)C(=O)[O-])=O)C(=CC=C1)Cl Chemical compound [Na+].ClC1=C(C=C2CCCC=3C(N4C(=NC23)C=CC(=C4)C(=O)[O-])=O)C(=CC=C1)Cl ADGSLKNSDCJMNW-UHFFFAOYSA-M 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000004479 aerosol dispenser Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical class [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001262 anti-secretory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical class C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical class CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical class CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- LGRLWUINFJPLSH-UHFFFAOYSA-N methanide Chemical compound [CH3-] LGRLWUINFJPLSH-UHFFFAOYSA-N 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- VIXFLVPILXCRME-UHFFFAOYSA-N methyl 11-oxo-1,2,3,4-tetrahydropyrido[2,1-b]quinazoline-8-carboxylate Chemical compound C1CCCC2=C1N=C1C=CC(C(=O)OC)=CN1C2=O VIXFLVPILXCRME-UHFFFAOYSA-N 0.000 description 1
- MNYHJEJITHQBJT-UHFFFAOYSA-N methyl 4-benzylidene-8-oxo-2,9-diazatetracyclo[7.5.0.03,7.010,12]tetradeca-1,3(7),13-triene-12-carboxylate Chemical compound C1=CC2(C(=O)OC)CC2N(C(C=2CC3)=O)C1=NC=2C3=CC1=CC=CC=C1 MNYHJEJITHQBJT-UHFFFAOYSA-N 0.000 description 1
- KSEAHCGXXNZUKX-UHFFFAOYSA-N methyl 4H-pyrido[1,2-a]pyrimidine-7-carboxylate Chemical compound COC(=O)C=1C=CC=2N(CC=CN2)C1 KSEAHCGXXNZUKX-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- DORROBMBVJXJHA-UHFFFAOYSA-N methyl quinazoline-8-carboxylate Chemical compound N1=CN=C2C(C(=O)OC)=CC=CC2=C1 DORROBMBVJXJHA-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- YPLIFKZBNCNJJN-UHFFFAOYSA-N n,n-bis(ethylamino)ethanamine Chemical compound CCNN(CC)NCC YPLIFKZBNCNJJN-UHFFFAOYSA-N 0.000 description 1
- QAXZWHGWYSJAEI-UHFFFAOYSA-N n,n-dimethylformamide;ethanol Chemical compound CCO.CN(C)C=O QAXZWHGWYSJAEI-UHFFFAOYSA-N 0.000 description 1
- WDPWQLZRUPLEHZ-UHFFFAOYSA-N n-[4-[(8-methyl-11-oxo-2,3-dihydro-1h-pyrido[2,1-b]quinazolin-4-ylidene)methyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1C=C1C(N=C2N(C=C(C)C=C2)C2=O)=C2CCC1 WDPWQLZRUPLEHZ-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000024717 negative regulation of secretion Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Substances ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8212429 | 1982-04-29 | ||
| GB838309259A GB8309259D0 (en) | 1983-04-06 | 1983-04-06 | Condensed cycloaliphatic derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU188274B true HU188274B (en) | 1986-03-28 |
Family
ID=26282687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU831451A HU188274B (en) | 1982-04-29 | 1983-04-27 | Process for producing condensed cycloalifatic derivatives of substituted pyrido (1,2-a)pyrimidones and pharmaceutical compositions containing them as acitve agents |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4521419A (enExample) |
| AT (1) | AT384808B (enExample) |
| AU (1) | AU557703B2 (enExample) |
| CA (1) | CA1192548A (enExample) |
| CH (1) | CH660485A5 (enExample) |
| CS (1) | CS233748B2 (enExample) |
| DE (1) | DE3315299A1 (enExample) |
| DK (1) | DK192683A (enExample) |
| ES (1) | ES8406476A1 (enExample) |
| FI (1) | FI74467C (enExample) |
| FR (1) | FR2526020B1 (enExample) |
| GR (1) | GR78546B (enExample) |
| HU (1) | HU188274B (enExample) |
| IL (1) | IL68505A (enExample) |
| IT (1) | IT1194215B (enExample) |
| LU (1) | LU84775A1 (enExample) |
| NL (1) | NL8301505A (enExample) |
| NO (1) | NO831503L (enExample) |
| NZ (1) | NZ204041A (enExample) |
| PH (1) | PH18388A (enExample) |
| PT (1) | PT76609B (enExample) |
| SE (1) | SE8302411L (enExample) |
| YU (1) | YU95583A (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63183581A (ja) * | 1985-10-03 | 1988-07-28 | Tokyo Tanabe Co Ltd | ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬 |
| CN112321465B (zh) * | 2019-07-18 | 2023-06-06 | 上海现代药物制剂工程研究中心有限公司 | 一种含苯基化合物、其中间体、制备方法及应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3965100A (en) * | 1975-02-26 | 1976-06-22 | E. R. Squibb & Sons, Inc. | 2,3-Dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10(1H)-one and its derivatives |
| US3935197A (en) * | 1975-05-16 | 1976-01-27 | E. R. Squibb & Sons, Inc. | 2-Styryl-4H-pyrido(1,2-a)pyrimidin-4-ones |
| US4033961A (en) * | 1975-10-07 | 1977-07-05 | Warner-Lambert Company | Pyrido[2-1-b]quinazolin-ones and their methods of preparation |
| DE2557425C2 (de) * | 1975-12-19 | 1987-03-19 | C.H. Boehringer Sohn, 6507 Ingelheim | 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel |
| HU174693B (hu) * | 1976-02-12 | 1980-03-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija kondensirovannykh proizvodnykh pirimidina |
| US4066767A (en) * | 1976-11-01 | 1978-01-03 | Warner-Lambert Company | 8-(1H-Tetrazol-5-yl)-11H-pyrido[2,1-b]quinazolin-11-ones and method of treating bronchial asthma using them |
| HU182009B (en) * | 1977-08-19 | 1983-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing substituted pirido-square bracket-1,2-a-square bracket closed-pyrimidines, pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines |
| AU527931B2 (en) * | 1979-05-08 | 1983-03-31 | Farmitalia Carlo Erba S.P.A. | Substituted pyrido(1,2-a)pyrimidines |
| AT377586B (de) * | 1981-06-30 | 1985-04-10 | Erba Farmitalia | Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen |
-
1983
- 1983-04-22 ES ES521739A patent/ES8406476A1/es not_active Expired
- 1983-04-26 FI FI831426A patent/FI74467C/fi not_active IP Right Cessation
- 1983-04-26 IT IT20779/83A patent/IT1194215B/it active
- 1983-04-26 GR GR71210A patent/GR78546B/el unknown
- 1983-04-27 YU YU00955/83A patent/YU95583A/xx unknown
- 1983-04-27 HU HU831451A patent/HU188274B/hu not_active IP Right Cessation
- 1983-04-27 AU AU13991/83A patent/AU557703B2/en not_active Ceased
- 1983-04-27 LU LU84775A patent/LU84775A1/fr unknown
- 1983-04-27 DE DE19833315299 patent/DE3315299A1/de not_active Withdrawn
- 1983-04-27 IL IL68505A patent/IL68505A/xx unknown
- 1983-04-27 US US06/489,057 patent/US4521419A/en not_active Expired - Fee Related
- 1983-04-27 PH PH28824A patent/PH18388A/en unknown
- 1983-04-28 CS CS833005A patent/CS233748B2/cs unknown
- 1983-04-28 CH CH2286/83A patent/CH660485A5/de not_active IP Right Cessation
- 1983-04-28 FR FR8307052A patent/FR2526020B1/fr not_active Expired
- 1983-04-28 AT AT0154883A patent/AT384808B/de not_active IP Right Cessation
- 1983-04-28 SE SE8302411A patent/SE8302411L/xx not_active Application Discontinuation
- 1983-04-28 DK DK192683A patent/DK192683A/da not_active Application Discontinuation
- 1983-04-28 NO NO831503A patent/NO831503L/no unknown
- 1983-04-28 NL NL8301505A patent/NL8301505A/nl not_active Application Discontinuation
- 1983-04-28 CA CA000426896A patent/CA1192548A/en not_active Expired
- 1983-04-28 PT PT76609A patent/PT76609B/pt unknown
- 1983-04-28 NZ NZ204041A patent/NZ204041A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2526020B1 (fr) | 1986-03-21 |
| SE8302411L (sv) | 1983-10-30 |
| LU84775A1 (fr) | 1983-11-17 |
| PH18388A (en) | 1985-06-19 |
| US4521419A (en) | 1985-06-04 |
| NZ204041A (en) | 1985-02-28 |
| IL68505A0 (en) | 1983-07-31 |
| AT384808B (de) | 1988-01-11 |
| DK192683A (da) | 1983-10-30 |
| ES521739A0 (es) | 1984-07-01 |
| GR78546B (enExample) | 1984-09-27 |
| PT76609B (en) | 1986-01-17 |
| FI831426A0 (fi) | 1983-04-26 |
| ATA154883A (de) | 1987-06-15 |
| FI74467B (fi) | 1987-10-30 |
| FI831426L (fi) | 1983-10-30 |
| DK192683D0 (da) | 1983-04-28 |
| IT1194215B (it) | 1988-09-14 |
| FR2526020A1 (fr) | 1983-11-04 |
| IT8320779A0 (it) | 1983-04-26 |
| NO831503L (no) | 1983-10-31 |
| CH660485A5 (de) | 1987-04-30 |
| DE3315299A1 (de) | 1983-11-03 |
| FI74467C (fi) | 1988-02-08 |
| YU95583A (en) | 1986-12-31 |
| ES8406476A1 (es) | 1984-07-01 |
| NL8301505A (nl) | 1983-11-16 |
| CS233748B2 (en) | 1985-03-14 |
| IT8320779A1 (it) | 1984-10-26 |
| IL68505A (en) | 1986-01-31 |
| CA1192548A (en) | 1985-08-27 |
| SE8302411D0 (sv) | 1983-04-28 |
| PT76609A (en) | 1983-05-01 |
| AU1399183A (en) | 1983-11-03 |
| AU557703B2 (en) | 1987-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU656859B2 (en) | Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent | |
| RU2136682C1 (ru) | Имидазопиридины, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции | |
| US4492702A (en) | 1-Phenyl-1,8-naphthridin-2(1H)-ones | |
| US4468400A (en) | Antiulcer tricyclic imidazo [1,2-a]pyridines | |
| NO159724B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazo(1,2-a)-pyraziner. | |
| JPH0146514B2 (enExample) | ||
| HU220066B (hu) | Imidazo[1,2-a]piridinek alkoxi-alkil-karbamátjai, alkalmazásuk, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HU191757B (en) | Process for producing new tricyclic ethers | |
| JPH0568476B2 (enExample) | ||
| FI68824B (fi) | Foerfarande foer framstaellning av terapeutiskt effektiva substituerade 2-etenyl-4-oxo-4h-pyrido(1,2-a)pyrimidiner | |
| US4816459A (en) | Tetrazolyl-substituted pyrido[1,2-a]pyrimidines and use as SRS-A antagonists | |
| HU188274B (en) | Process for producing condensed cycloalifatic derivatives of substituted pyrido (1,2-a)pyrimidones and pharmaceutical compositions containing them as acitve agents | |
| KR900004831B1 (ko) | 폴리시클릭퀴놀린, 나프티리딘 및 피라지노피리딘 유도체 | |
| NZ197476A (en) | 5,7-dihydro-imidazo(1,2-a)thieno(3,2-d)pyrimid-6,9-diones | |
| JPS588082A (ja) | 置換されたピロロ〔２，１−ｂ〕キナゾリンおよびピリド〔２，１−ｂ〕キナゾリンおよびそれらの製造法 | |
| HU190945B (en) | Process for preparing substituted thiazolo/3,2-a/pyrimidine-carb oxylic acid derivatives | |
| GB2119795A (en) | Condensed cycloaliphatic derivatives of substituted pyrido [1,2-a] pyrimidines | |
| JPH0386884A (ja) | ベンゾピラノピリジン誘導体 | |
| JPH10505330A (ja) | ハロゲンイミダゾピリジン | |
| HU200768B (en) | Process for producing aryl-substituted naphthyridine derivatives an dpharmaceutical compositions comprising same | |
| JPS58194888A (ja) | 置換されたピリド〔１．２−ａ〕ピリミジンの縮合環状脂肪族誘導体 | |
| HU188929B (en) | Process for the production of benzylidene-pyrrolo /2,1-b/ quinazolines and benzylidene-pyrido /2,1-b/ quinazoline amino-derivatives | |
| JPH0428270B2 (enExample) | ||
| JPH01319488A (ja) | テトラヒドロイミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤 | |
| GB2133789A (en) | Thiazolo[3,2-a]pyrimidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 | ||
| HMM4 | Cancellation of final prot. due to non-payment of fee |